HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rizzo, W. B. Articles by Craft, D. A. Search for Related Content PubMed PubMed Citation Articles by Rizzo, W. B. Articles by Craft, D. A. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 1077-1081, July 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Sjögren–Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma

Correspondence to: William B. Rizzo

Sjögren–Larsson syndrome (SLS) is an inherited disorder associated with deficient oxidation of long-chain aliphatic alcohols. Previous studies have reported modest elevations in total (free + esterified) fatty alcohols in SLS, but free fatty alcohols have not been selectively measured, in part because of their low concentrations in most tissues and the presence of trace fatty alcohol contaminants in some solvents used for their analysis. We adapted methods to measure free fatty alcohols in cultured cells and plasma that minimize exogenous alcohol contamination. Fatty alcohols were analyzed as acetate derivatives, using capillary column gas chromatography. By this method, cultured skin fibroblasts from SLS patients were found to have 7- and 8-fold elevations in the mean content of hexadecanol (16:0-OH) and octadecanol (18:0-OH), respectively. The mean plasma 16:0-OH and 18:0-OH concentrations in SLS patients (n = 11) were 9- and 22-fold higher than in normal controls, respectively. In SLS fibroblasts, most of the fatty alcohol (59%) that accumulated was free rather than esterified alcohol, whereas free alcohol accounted for 23% of the total alcohol in normal cells.

These results indicate that elevations in free fatty alcohols provide a sensitive marker for the enzymatic defect in SLS. The ability to measure free fatty alcohols in cultured cells and plasma should prove useful for investigations of normal fatty alcohol metabolism and the deranged metabolism in SLS.—Rizzo, W. B., and D. A. Craft. Sjörgren–Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma. J. Lipid Res. 2000. 41: 1077–1081.

Supplementary key words: metabolic disease, ichthyosis, mental retardation, spasticity, wax esters, ether lipids

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. M. Elias, M. L. Williams, W. M. Holleran, Y. J. Jiang, and M. Schmuth Thematic review series: Skin Lipids. Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism J. Lipid Res., April 1, 2008; 49(4): 697 - 714. [Abstract] [Full Text] [PDF]

				W. B. Rizzo, D. A. Craft, T. Somer, G. Carney, J. Trafrova, and M. Simon Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjogren-Larsson syndrome J. Lipid Res., February 1, 2008; 49(2): 410 - 419. [Abstract] [Full Text] [PDF]

				D. M. van den Brink, J. M. van Miert, and R. J.A. Wanders Assay for Sjogren-Larsson Syndrome Based on a Deficiency of Phytol Degradation Clin. Chem., January 1, 2005; 51(1): 240 - 242. [Full Text] [PDF]

				M. A. A. P. Willemsen, M. van der Graaf, M. S. van der Knaap, A. Heerschap, P. H. M. F. van Domburg, F. J. M. Gabreels, and J. J. Rotteveel MR Imaging and Proton MR Spectroscopic Studies in Sjogren-Larsson Syndrome: Characterization of the Leukoencephalopathy AJNR Am. J. Neuroradiol., April 1, 2004; 25(4): 649 - 657. [Abstract] [Full Text] [PDF]

				J. L. Hargrove, P. Greenspan, and D. K. Hartle Nutritional Significance and Metabolism of Very Long Chain Fatty Alcohols and Acids from Dietary Waxes Experimental Biology and Medicine, March 1, 2004; 229(3): 215 - 226. [Abstract] [Full Text] [PDF]

				J. O. Nwankwo, A. A. Spector, and F. E. Domann A nucleotide insertion in the transcriptional regulatory region of FADS2 gives rise to human fatty acid delta-6-desaturase deficiency J. Lipid Res., December 1, 2003; 44(12): 2311 - 2319. [Abstract] [Full Text] [PDF]

				M. A. A. P. Willemsen, L. IJlst, P. M. Steijlen, J. J. Rotteveel, J. G. N. de Jong, P. H. M. F. van Domburg, E. Mayatepek, F. J. M. Gabreels, and R. J. A. Wanders Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjogren-Larsson syndrome Brain, July 1, 2001; 124(7): 1426 - 1437. [Abstract] [Full Text] [PDF]

				D. E. Williard, J. O. Nwankwo, T. L. Kaduce, S. D. Harmon, M. Irons, H. W. Moser, G. V. Raymond, and A. A. Spector Identification of a fatty acid {{Delta}}6-desaturase deficiency in human skin fibroblasts J. Lipid Res., April 1, 2001; 42(4): 501 - 508. [Abstract] [Full Text]